Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer’s disease is safe

AI Summary

- Phase I trial results have been reported regarding cellular senescence in Alzheimer's disease. - The study focuses on a promising area of research for Alzheimer's disease, cellular senescence. - Summary unavailable.

Scientists are reporting results from a Phase I trial in an area of promising research for Alzheimer’s disease — cellular senescence.

Leave a Reply